-+ 0.00%
-+ 0.00%
-+ 0.00%

ASTRAZENECA: BREZTRI IS NOW AVAILABLE IN US AS FIRST AND ONLY FIXED-DOSE TRIPLE THERAPY FOR ASTHMA PATIENTS 12 YEARS OF AGE AND OLDER

Reuters·07/20/2026 13:36:49

Please log in to view news